Comparative safety and immunogenicity trial of two killed Leishmania Major vaccines with or without BCG in human volunteers
- 31 October 1996
- journal article
- clinical trial
- Published by Elsevier in Clinics in Dermatology
- Vol. 14 (5) , 489-495
- https://doi.org/10.1016/0738-081x(96)00071-5
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis.The Journal of Immunology, 1993
- Establishment of Stable, Cell-Mediated Immunity that Makes "Susceptible" Mice Resistant to Leishmania majorScience, 1992
- Evaluation of the stability of a soluble intradermal skin test antigen preparation in American visceral leishmaniasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1990
- Controlled Field Trials of a Vaccine Against New World Cutaneous LeishmaniasisInternational Journal of Epidemiology, 1986
- An experimental vaccine against American dermal leishmaniasis: experience in the State of Espírito Santo, BrazilPathogens and Global Health, 1985
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Measurement of Delayed Skin-Test ResponsesNew England Journal of Medicine, 1975
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951